A multicenter research effort in China conducted clinical trial testing of oral berberine for six months in diabetes-free ...

Severe maternal disease and preterm birth due to COVID-19 infection are less prevalent when immunization occurs before or during pregnancy, demonstrating the clinical benefit of vaccination in ...

The key question now is how much worse can it get for software when areas like semiconductors are pushing to new all-time ...

Learn about NTSI, a 90% global equity/60% US Treasury ETF, its risk-adjusted return potential, and 2022-style risks—see if it fits your portfolio.

A new, non-peer-reviewed report argues that Egypt’s Great Pyramid may be far older than the familiar Old Kingdom timeline, proposing an age in the order of tens of thousands of years. The claim hinges ...

Discover how quantitative analysis can illuminate hedge fund performance, offering insights into risk metrics and benchmarks ...

Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

IMCG ETF review: low-cost (0.06%) mid-cap growth exposure using forward-looking fundamentals, recent outperformance, key ...

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders to restore it.

One large international study demonstrated that severe hypoxia during attempted intubation of critically ill patients occurs ...

Despite a decrease in spread multiples, the private insurance-linked securities (ILS) market continues to remain attractive ...

Explore how differences in bond type, tax treatment, and liquidity set these two short-term ETFs apart for income-focused ...